Changes in the use of the methylprednisolone protocol for traumatic spinal cord injury in Switzerland

Spine

Volumn 37, Issue 11, 2012, Pages 953-956

  Felleiter, Peter ^a   Müller, Nicole ^a   Schumann, Frederik ^a   Felix, Olga ^a   Lierz, Peter ^a  

^a SWISS PARAPLEGIC RESEARCH   (Switzerland)

Author keywords

functional recovery; methylprednisolone; neuroprotection; outcomes; spinal cord injuries

Indexed keywords

METHYLPREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG MEGADOSE; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; PHYSICIAN; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REHABILITATION CARE; RETROSPECTIVE STUDY; SENSORIMOTOR FUNCTION; SPINAL CORD INJURY; SWITZERLAND; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SPINAL CORD INJURIES; SWITZERLAND; YOUNG ADULT;

EID: 84861098383     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31823a07a2     Document Type: Article

References (18)

1. Felleiter P, Reinbott S, Michel F, et al. Das traumatische Querschnittssyndrom. Schweiz Med Forum 2004;4:1166-72.
2. Rowland JW, Hawryluk GW, Kwon B, et al. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008;25:E2.
3. Bracken MB, Collins WF, Freeman DF, et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 1984;251:45-52.
4. Bracken MB, Shepard MJ, Hellenbrand KG, et al. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg 1985;63:704-13.
5. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990;322:1405-11.
6. Bracken MB, Shepard MJ, Collins WF Jr, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year followup data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 1992;76:23-31.
7. Bracken MB, Shepard MJ, Holford TR, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998;89:699-706.
8. Qian T, Guo X, Levi AD, et al. High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord 2005;43:199-203.
9. Short DJ, El Masry WS, Jones PW. High dose methylprednisolone in the management of acute spinal cord injury-a systematic review from a clinical perspective. Spinal Cord 2000;38:273-86.
10. Himmelseher S, Büttner J, Baethmann A, et al. Zur Gabe von Kortikosteroiden nach akuter spinaler Traumatisierung. Anästhesiologie & Intensivmedizin 1999;40:716-26.
11. Fitzal S. Hochdosiertes Methylprednisolon beim spinalen Trauma. Internationale Zeitschrift für ärztliche Fortbildung 2006;1:1-8.
12. Jeanneret B, Mäder M. Hochdosiertes Methylprednisolon in der Behandlung des akut Querschnittverletzten. Schweiz Med Forum 2008;8:258-9.
13. American Spinal Injury Association. International Standards for Neurological Classification of Spinal Cord Injury. Rev 2002 ed. Chicago, IL: American Spinal Injury Association; 2002.
14. Institute of Medicine. Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press; 1990.
15. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.
16. Hurlbert RJ, Hamilton MG. Methylprednisolone for acute spinal cord injury: 5-year practice reversal. Can J Neurol Sci 2008;35:41-5.
17. Nicholas JS, Selassie AW, Lineberry LA, et al. Use and determinants of the methylprednisolone protocol for traumatic spinal cord injury in South Carolina acute care hospitals. J Trauma 2009;66:1446-50; discussion 50.
18. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003;31:359-66.